SQUINTO STEPHEN P 4
4 · SpringWorks Therapeutics, Inc. · Filed May 21, 2021
Insider Transaction Report
Form 4
SQUINTO STEPHEN P
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-05-20+6,998→ 6,998 totalExercise: $75.94Exp: 2031-05-20→ Common Stock (6,998 underlying) - Award
Common Stock
2021-05-20+1,106→ 126,834 total
Holdings
- 6,186,307(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Represents restricted stock awards. The restricted stock awards shall vest in full on the earlier of (1) May 20, 2022 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.
- [F2]Shares held by OrbiMed Private Investments VI, LP ("OrbiMed VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OrbiMed VI. OrbiMed Advisors, LLC ("Advisors") is the managing member of GP VI. By virtue of such relationship, GP VI and Advisors may be deemed to have voting and investment power with respect to the shares held by OrbiMed VI and as a result may be deemed to have beneficial ownership of such shares. The reporting person is an Executive Partner at Advisors. This report shall not be deemed an admission that the reporting person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- [F3]The options shall vest in full on the earlier of (1) May 20, 2022 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.